Abstract |
Breakthroughs in understanding the epigenetic mechanisms involved in neurodegenerative disease have highlighted "epidrugs" as a potential avenue for therapeutic development. Here, we expand on the future of epidrugs against neurodegeneration and discuss promising novel targets underexploited thus far: histone kinases.
|
Authors | Samantha N Cobos, Mariana P Torrente |
Journal | ACS pharmacology & translational science
(ACS Pharmacol Transl Sci)
Vol. 5
Issue 2
Pg. 134-137
(Feb 11 2022)
ISSN: 2575-9108 [Electronic] United States |
PMID | 35187420
(Publication Type: Journal Article)
|
Copyright | © 2022 American Chemical Society. |